Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.610
-0.010 (-0.38%)
At close: Dec 20, 2024, 4:00 PM
2.660
+0.050 (1.92%)
After-hours: Dec 20, 2024, 7:16 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $3.16 million as of December 20, 2024. Its market cap has decreased by -47.22% in one year.
Market Cap
3.16M
Enterprise Value
1.87M
1-Year Change
-47.22%
Ranking
Category
Stock Price
$2.61
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $3.16M, a decrease of -90.36%. That is a compound annual growth rate of -68.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.16M | -46.70% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 3.20M |
| ReShape Lifesciences | 3.19M |
| Petros Pharmaceuticals | 3.13M |
| Tharimmune | 3.12M |
| iCoreConnect | 3.12M |
| Processa Pharmaceuticals | 3.08M |
| China Pharma Holdings | 3.07M |
| Artelo Biosciences | 3.05M |